Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:IVF NASDAQ:LFWD NASDAQ:LUCY NASDAQ:STRR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIVFINVO Fertility$0.79-2.0%$1.28$0.74▼$17.04$1.70M2.041.15 million shs31,580 shsLFWDLifeward$0.71-2.1%$1.06$0.50▼$4.77$7.83M0.02830,019 shs215,495 shsLUCYInnovative Eyewear$2.15-0.7%$2.50$1.57▼$11.16$6.65M3.221.25 million shs53,087 shsSTRRStar Equity$1.98+0.8%$2.11$1.72▼$5.35$6.34M0.9316,574 shs11,177 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIVFINVO Fertility+1.65%-5.66%-38.79%+80,189,900.00%+80,189,900.00%LFWDLifeward-3.20%-5.52%-34.00%-47.77%-81.38%LUCYInnovative Eyewear+0.47%-0.46%-11.84%+17.39%-72.48%STRRStar Equity0.00%0.00%-3.45%+3.76%-59.34%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationIVFINVO FertilityN/AN/AN/AN/AN/AN/AN/AN/ALFWDLifeward2.6564 of 5 stars3.52.00.00.03.80.01.3LUCYInnovative Eyewear0.4419 of 5 stars0.02.00.00.03.30.00.6STRRStar Equity3.5963 of 5 stars3.55.00.00.02.71.71.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceIVFINVO Fertility 0.00N/AN/AN/ALFWDLifeward 3.00Buy$9.001,165.82% UpsideLUCYInnovative Eyewear 0.00N/AN/AN/ASTRRStar Equity 3.00Buy$5.00153.16% UpsideCurrent Analyst Ratings BreakdownLatest IVF, LFWD, LUCY, and STRR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/15/2025STRRStar EquityMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$8.00 ➝ $5.00(Data available from 7/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookIVFINVO Fertility$6.53M0.26N/AN/A($29.86) per share-0.03LFWDLifeward$25.41M0.31N/AN/A$2.14 per share0.33LUCYInnovative Eyewear$1.64M4.05N/AN/A$3.72 per share0.58STRRStar Equity$53.36M0.12$0.33 per share6.01$10.98 per share0.18Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateIVFINVO Fertility-$9.10M-$34.06N/A∞N/A-377.73%N/A-88.18%N/ALFWDLifeward-$28.94M-$3.04N/AN/AN/A-108.21%-101.96%-70.49%8/13/2025 (Estimated)LUCYInnovative Eyewear-$7.77M-$3.99N/A∞N/A-443.18%-86.90%-81.36%8/11/2025 (Estimated)STRRStar Equity-$10.44M-$3.43N/AN/AN/A-16.43%-8.24%-3.48%8/12/2025 (Estimated)Latest IVF, LFWD, LUCY, and STRR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q2 2025LFWDLifeward-$0.25N/AN/AN/A$6.62 millionN/A8/12/2025Q2 2025STRRStar Equity-$0.26N/AN/AN/A$16.75 millionN/A5/20/2025Q1 2025IVFINVO FertilityN/A-$12.53N/A-$12.53N/A$1.64 million5/15/2025Q1 2025LFWDLifeward-$0.33-$0.46-$0.13-$0.46$5.84 million$5.03 million5/14/2025Q1 2025STRRStar Equity-$0.25-$0.52-$0.27-$0.37$16.35 million$12.92 million5/13/2025Q1 2025LUCYInnovative Eyewear-$0.73-$0.72+$0.01-$0.72$1.00 million$0.46 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthIVFINVO FertilityN/AN/AN/AN/AN/ALFWDLifewardN/AN/AN/AN/AN/ALUCYInnovative EyewearN/AN/AN/AN/AN/ASTRRStar EquityN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioIVFINVO FertilityN/A0.080.07LFWDLifewardN/A2.181.43LUCYInnovative EyewearN/A16.4013.02STRRStar Equity0.221.420.88Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipIVFINVO Fertility12.02%LFWDLifeward26.76%LUCYInnovative Eyewear0.96%STRRStar Equity3.84%Insider OwnershipCompanyInsider OwnershipIVFINVO Fertility0.57%LFWDLifeward2.70%LUCYInnovative Eyewear6.42%STRRStar Equity33.51%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableIVFINVO Fertility102.16 million2.15 millionN/ALFWDLifeward6011.01 million10.71 millionOptionableLUCYInnovative Eyewear93.10 million2.90 millionNot OptionableSTRRStar Equity4603.21 million2.13 millionNot OptionableIVF, LFWD, LUCY, and STRR HeadlinesRecent News About These CompaniesSTAR EQUITY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Star Equity ...May 24, 2025 | morningstar.comM$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Star Equity Holdings, Inc. (NASDAQ: STRR)May 24, 2025 | financialpost.comF$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Star Equity Holdings, Inc. (NASDAQ: STRR)May 24, 2025 | financialpost.comF$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Star Equity Holdings, Inc. (NASDAQ: STRR)May 24, 2025 | globenewswire.comSTAR EQUITY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Star Equity Holdings, Inc. - STRRMay 22, 2025 | businesswire.comStar Equity Holdings, Inc. Declares Cash Dividend of $0.25 for Preferred StockholdersMay 22, 2025 | nasdaq.comHudson Global, Inc.: Star Equity Holdings and Hudson Global Sign Definitive Merger AgreementMay 22, 2025 | finanznachrichten.deSTRR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Star Equity Holdings, Inc. Is Fair to ShareholdersMay 21, 2025 | businesswire.comStar Equity Holdings, Inc. and Hudson Global, Inc. Announce Definitive Merger Agreement to Form NewCoMay 21, 2025 | quiverquant.comQStar Equity Holdings, Inc. and Hudson Global, Inc. Announce Merger Agreement to Form NewCoMay 21, 2025 | quiverquant.comQStar Equity Holdings and Hudson Global Sign Definitive Merger AgreementMay 21, 2025 | globenewswire.comStar Equity Holdings Declares Cash Dividend for Preferred StockMay 20, 2025 | tipranks.comStar Equity Holdings, Inc. Declares Cash Dividend of $0.25 Per Share of 10% Series A Cumulative Perpetual Preferred StockMay 20, 2025 | globenewswire.comStar Equity signals record $27.9M backlog while advancing Energy Services integrationMay 15, 2025 | msn.comStar Equity Holdings Inc (STRR) Q1 2025: Everything You Need To Know Ahead Of EarningsMay 15, 2025 | finance.yahoo.comStar Equity Holdings, Inc. (NASDAQ:STRR) Q1 2025 Earnings Call TranscriptMay 15, 2025 | insidermonkey.comStar Equity Holdings, Inc. (STRR) Q1 2025 Earnings Call TranscriptMay 14, 2025 | seekingalpha.comStar Equity (STRR) Reports Q1 Loss, Misses Revenue EstimatesMay 14, 2025 | zacks.comStar Equity Holdings, Inc. Announces 2025 First Quarter Financial Results | STRR Stock NewsMay 14, 2025 | gurufocus.comStar Equity Holdings, Inc. Announces 2025 First Quarter Financial ResultsMay 14, 2025 | gurufocus.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeIVF, LFWD, LUCY, and STRR Company DescriptionsINVO Fertility NASDAQ:IVF$0.79 -0.02 (-2.01%) As of 12:47 PM EasternNAYA Biosciences (NASDAQ: NAYA) is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and fertility. Our hub & spoke model harnesses the shared resources of a parent company and agility of lean strategic franchises, enabling efficient acquisition, development, and partnering of assets as well as optimized return on investment by combining the upside of innovative clinical-stage therapeutics with scalable, profitable commercial revenues. NAYA’s expanding portfolio of assets currently includes NY-303, a GPC3 and NKp46 targeting bispecific antibody for the treatment of hepatocellular carcinoma (HCC) with a unique mode of action targeting non-responders to the current immunotherapy standard of care (approximately 70% of the current treatable market) cleared to enroll patients in a Phase I/II monotherapy trial in early 2025, NY-338, a CD38 and NKp46 targeting bispecific antibody for the treatment of multiple myeloma and autoimmune diseases with a differentiated safety and efficacy profile, and INVOcell®, an FDA-approved fertility device which has demonstrated comparable success rates to traditional In Vitro Fertilization (IVF).Lifeward NASDAQ:LFWD$0.71 -0.02 (-2.07%) As of 01:08 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.Innovative Eyewear NASDAQ:LUCY$2.14 -0.02 (-0.69%) As of 01:08 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. In addition, the company launches an application, Lucyd app for iOS/Android users. It sells its products through various e-commerce, and retail store and distribution channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. is a subsidiary of Lucyd Ltd.Star Equity NASDAQ:STRR$1.98 +0.02 (+0.77%) As of 12:48 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Star Equity Holdings, Inc. engages in the construction business in the United States and internationally. It operates through two segments: Construction, and Investments. It manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters 3 Analysts Set $600 Target Ahead of Microsoft Earnings JPMorgan Q2 Results Affirm Dividend, Buybacks, & Growth NVDA Greenlight: China H20 Sales Spark 50% Rally Potential Tesla: 2 Plays Ahead of Next Week's Earnings Report New Catalyst Sends Joby Stock to 52-Week Highs Palantir Gets Price Hike From Wedbush Amid High Valuation Delta Air Lines Stock Rallies on New Guidance—Can It Keep Going? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
